These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1835876)
1. Clinical trials referral resource. Bone marrow transplantation for breast cancer. Cheson BD Oncology (Williston Park); 1991 Sep; 5(9):55, 58, 61-3. PubMed ID: 1835876 [No Abstract] [Full Text] [Related]
2. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes. Peters WP Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808 [No Abstract] [Full Text] [Related]
4. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out. Smith GA; Henderson IC Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807 [No Abstract] [Full Text] [Related]
5. Autologous bone marrow support and bone disease in metastatic breast cancer. Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplants do not help in breast cancer. Gottlieb S West J Med; 1999 Jun; 170(6):376. PubMed ID: 10443167 [No Abstract] [Full Text] [Related]
8. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989 [No Abstract] [Full Text] [Related]
9. Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience. Peters WP Prog Clin Biol Res; 1990; 354B():185-94. PubMed ID: 2236164 [No Abstract] [Full Text] [Related]
11. Autologous bone marrow transplantation in the treatment of breast cancer: clinical and technologic strategies. Vaughan WP Semin Oncol; 1993 Oct; 20(5 Suppl 6):55-8. PubMed ID: 8211216 [TBL] [Abstract][Full Text] [Related]
12. Dose intensity studies in breast cancer--autologous bone marrow transplantation. Hortobagyi GN; Dunphy F; Buzdar AU; Spitzer G Prog Clin Biol Res; 1990; 354B():195-209. PubMed ID: 2236166 [No Abstract] [Full Text] [Related]
13. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care. Cunningham R Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749 [No Abstract] [Full Text] [Related]
14. High-dose chemotherapy for breast cancer. Gratwohl A; Baldomero H; Rosti G Bone Marrow Transplant; 2000 Sep; 26(6):599. PubMed ID: 11041563 [No Abstract] [Full Text] [Related]
19. Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision. Schulman KA; Glick HA J Natl Cancer Inst Monogr; 1995; (19):45-50. PubMed ID: 7577205 [TBL] [Abstract][Full Text] [Related]